Taxus Companies Clash With Conor Over European Paclitaxel Patent
This article was originally published in The Pink Sheet Daily
Executive Summary
Boston Scientific's suit against Conor Medsystems over paclitaxel will draw from a $75 mil. legal reserve established by the Taxus manufacturer in 2004. Angiotech is joining Boston Scientific in suing Conor over the CoStar drug-eluting stent, seeking to halt use of clinical trial data, potential sales.